FOXL2 gene mutations and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES): A novel mutation detected in a Chinese family and a statistic model for summarizing previous reported records

Mutagenesis

Volumn 24, Issue 5, 2009, Pages 447-453

  Xu, Yan ^a   Lei, Huo ^a   Dong, Hong ^a   Zhang, Liping ^a   Qin, Qionglian ^a   Gao, Jianmei ^a   Zou, Yunlian ^a   Yan, Xinmin ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BLEPHAROPHIMOSIS; BLEPHAROPHIMOSIS PTOSIS EPICANTHUS INVERSUS SYNDROME; CHINESE; CLINICAL ARTICLE; DNA SEQUENCE; FOXL2 GENE; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PTOSIS; STATISTICAL MODEL;

ABNORMALITIES, MULTIPLE; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BLEPHAROPHIMOSIS; BLEPHAROPTOSIS; CHINA; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MODELS, STATISTICAL; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; SYNDROME;

EID: 71949126279     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gep028     Document Type: Article

References (42)

1. Oley, C. and Baraitser, M. (1988) Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES syndrome). J. Med. Genet., 25, 47-51.
2. Zlotogora, J., Sagi, M. and Cohen, T. (1983) The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am. J. Hum. Genet., 35, 1020-1027.
3. Fukushima, Y., Wakui, K., Nishida, T. and Ueoka, Y. (1991) Blepharophimosis sequence and de novo balanced autosomal translocation[46, XY, t(3;4)(q23p15.2)]: Possible assignment of the trait to 3q23. Am. J. Med. Genet., 40, 485-487.
4. Fryns, J. P., Stromme, P. and Berghe, H. V. (1993) Further evidence for the location of the blepharophimosis syndrome (BPES) at 3q22.3-q23. Clin. Genet., 44, 149-151.
5. Small, K. W., Stalvey, M. L., Fisher, L. et al. (1995) Blepharophimosis syndrome is linked to chromosome 3q. Hum. Mol. Genet., 4, 443-448.
6. Amati, P., Gasparini, P., Zlotogora, J., Zelante, L., Chomel, J. C., Kitzis, A., Kaplan, J. and Bonneau, D. (1996) A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22- q23. Am. J. Hum. Genet., 58, 1089-1092.
7. Praphanphoj, V., Goodman, B. K., Thomas, G. H., Niel, K. M., Toomes, C., Dixon, M. J. and Geraghty, M. T. (2000) Molecular cytogenetic evaluation in a patient with a translocation (3;21) associated with blepharophimosis, ptosis, epicanthus inversus syndrome (BPES). Genomics, 65, 67-69.
8. Crisponi, L., Deiana, M., Loi, A. et al. (2001) The pupative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat. Genet., 27, 159-166.
9. De Baere, E., Beysen, D., Oley, C. et al. (2003) FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype- phenotype correlation. Am. J. Hum. Genet., 72, 478-487.
10. Cocquet, J., De Baere, E., Gareil, M., Pannetier, M., Xia, X., Fellous, M. and Veitia, R. A. (2003) Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet. Genome Res., 101, 206-211.
11. Uhlenhaut, N. H. and Treier, M. (2006) FOXL2 function in ovarian development. Mol. Genet. Metab., 88, 225-234.
12. Batista, F., Vaiman, D., Dausset, J., Fellous, M. and Veitia, R. A. (2007) Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc. Natl Acad. Sci. USA, 104, 3330-3335.
13. De Baere, E., Dixon, M. J., Small, K. W. et al. (2001) Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum. Mol. Genet., 15, 1591-1600.
14. Ramirez-Castro, J. L., Pineda-Trujillo, N., Valencia, A. V. et al. (2002) Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families. Am. J. Med. Genet., 113, 916-922.
15. Qian, X. Q., Shu, A. L., Qin, W., Xing, Q. H., Gao, J. J., Yang, J. D., Guo, G. Y. and He, L. (2004) A novel insertion mutation in the FOXL2 gene is detected in a big Chinese family with Blepharophimosis-ptosis- epicanthus inversus. Mutat. Res., 554, 19-22.
16. Li, W. X., Wang, X. K., Sun, Y., Wang, Y. L., Lin, L. X. and Tang, S. J. (2005) A novel mutation in the FOXL2 gene in a Chinese family with blepharophimosis, ptosis, and epicanthus inversus syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 22, 372-375.
17. Qi, Y. H., Li, Y., Lin, H., Jia, H. Y., Su, H., Gu, J. Z., Huang, S. Z. and Liu, Y. P. (2006) Mutation analysis of FOXL2 in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Zhonghua Yan Ke Za Zhi, 42, 409-414. (Pubitemid 44018331)
18. Or, S. F., Tong, M. F., Lo, F. M. and Lam, T. S. (2006) Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Chin. Med. J (Engl.), 119, 49-52.
19. Tang, S., Wang, X., Lin, L., Sun, Y., Wang, Y. and Yu, H. (2006) Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosisptosis- epicanthus inversus syndrome. Mutagenesis, 21, 35-39.
20. Wang, J., Liu, J. L. and Zhang, Q. J. (2007) FOXL2 mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Mol. Vis., 26, 108-113.
21. Nallathambi, J., Neethirajan, G., Usha, K., Jitendra, J., De Baere, E. and Sundaresan, P. (2007) FOXL2 mutations in Indian families with blepharophimosis-ptosis-epicanthus inversus syndrome. J. Genet., 86, 165-168.
22. Beysen, D., De Jaegere, S., Amor, D. et al. (2008) Identification of 34 novel and 56 known FOXL2 mutations in patients with blepharophimosis syndrome. Hum. Mutat., 29, 205-219.
23. Leon-Mateos, A., Ginarte, M., Ruiz-Ponte, C., Carracedo, A. and Toribio, J. (2007) Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Int. J. Dermatol., 46, 61-63.
24. Moore, J. H., Gilbert, J. C., Tsai, C. T., Chiang, F. T., Holden, T., Barney, N. and White, B. C. (2006) A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J. Theor. Biol., 241, 252-261.
25. Bastone, L., Reilly, M., Rader, D. J. and Foulkes, A. S. (2004) MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum. Hered., 58, 82-92.
26. Lavoie, H., Debeane, F., Trinh, Q. D. et al. (2003) Polymorphism, shared functions and convergent evolution of genes with sequences coding for polyalanine domains. Hum. Mol. Genet., 12, 2967-2979.
27. Muragaki, Y., Mundlos, S., Upton, J. and Olsen, B. R. (1996) Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science, 272, 548-551.
28. Brown, L. Y. and Brown, S. A. (2004) Alanine tracts: The expanding story of human illness and trinucleotide repeats. Trends Genet., 20, 51-58.
29. Caburet, S., Demarez, A., Moumne, L., Fellous, M., De Baere, E. and Veitia, R. A. (2004) A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J. Med. Genet., 41, 932-936.
30. Albrecht, A. N., Kornak, U., Böddrich, A. et al. (2004) A molecular pathogenesis for transcription factor associated poly-alanine tract expansions. Hum. Mol. Genet., 13, 2351-2359.
31. Lin, L. X., Tang, S. J., Wang, X. K., Sun, Y. and Wang, Y. L. (2007) Mutation analysis of FOXL2 gene and its structure protein in patients of blepharophimosis-ptosis-epicanthus inversus syndrome. Zhonghua Yan Ke Za Zhi, 43, 535-539.
32. Moumne, L., Dipietromaria, A., Batista, F., Kocer, A., Fellous, M., Pailhoux, E. and Veitia, R. A. (2008) Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum. Mol. Genet., 17, 1010-1019.
33. Beysen, D., Moumne, L., Veitia, R., Peters, H., Leroy, B. P., De Paepe, A. and De Baere, E. (2008) Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation. Hum. Mol. Genet., 17, 2030-2038.
34. Moumne, L., Fellous, M. and Veitia, R. A. (2005) Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation. Hum. Mol. Genet., 14, 3557-3564.
35. Skillern, A. and Rajkovic, A. (2008) Recent developments in identifying genetic determinants of premature ovarian failure. Sex. Dev., 2, 228-243.
36. Uhlenhaut, N. H. and Treier, M. (2006) Foxl2 function in ovarian development. Mol. Genet. Metab., 88, 225-234.
37. Bodega, B., Porta, C., Crosignani, P. G., Ginelli, E. and Marozzi, A. (2004) Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol. Hum. Reprod., 10, 555-557.
38. Nallathambi, J., Laissue, P., Batista, F. et al. (2008) Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients. Hum. Mutat., 29, E123-E131.
39. Nallathambi, J., Moumne, L., De Baere, E., Beysen, D., Usha, K., Sundaresan, P. and Veitia, R. A. (2007) A novel polyalanine expansion in FOXL2: The first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. Hum. Genet., 121, 107-112.
40. Beysen, D., Raes, J., Leroy, B. P. et al. (2005) Deletions involving longrange conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am. J. Hum. Genet., 77, 205-218.
41. Tzschach, A., Kelbova, C., Weidensee, S. et al. (2008) Blepharophimosisptosis- epicanthus inversus syndrome in a girl with chromosome translocation t(2;3)(q33;q23). Ophthalmic Genet., 29, 37-40.
42. Beysen, D., De Paepe, A. and De Baere, E. (2009) FOXL2 mutations and genomic rearrangements in BPES. Hum. Mutat., 30, 158-169.